Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | 41407456 | PubTator, text mining | PubMed |
| Prediction of liquid-liquid phase separation proteins based on protein language model. | Brief Bioinform | 2025 | 41405960 | PubTator, text mining | PubMed |
| A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers. | bioRxiv | 2025 | 41279690 | PubTator, text mining | PubMed |
| Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by SRSF2 mutations and reduced by RUNX1 loss. | bioRxiv | 2025 | 41279606 | PubTator, text mining | PubMed |
| Targeting UBE2B-mediated U2AF1 degradation to alleviate endothelial dysfunction in renal ischemia-reperfusion injury: therapeutic potential of semaglutide. | Mol Biol Rep | 2025 | 41186784 | PubTator, text mining | PubMed |
| Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on U2AF1. | J Clin Med | 2025 | 41096153 | PubTator, text mining | PubMed |
| Discovery of the U2AF1-UHM Inhibitor That Possesses Anti-Leukemia Activity In Vitro. | ACS Med Chem Lett | 2025 | 41089473 | PubTator, text mining | PubMed |
| [Deregulated RNA processing in leukemias]. | Rinsho Ketsueki | 2025 | 41034083 | PubTator, text mining | PubMed |
| A Relapsed AML Case Featuring MYC and MECOM Rearrangements. | Diagnostics (Basel) | 2025 | 41008781 | PubTator, text mining | PubMed |
| Dynamic U2AF cycling defines two phases of cotranscriptional pre-mRNA splicing. | Science | 2025 | 40997183 | PubTator, text mining | PubMed |
Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in FLT3-ITD acute myeloid leukemia patients: A multi-center, retrospective study. | Chin J Cancer Res | 2025 | 40979666 | PubTator, text mining | PubMed |
| Requirements for establishment and epigenetic stability of mammalian heterochromatin. | Mol Cell | 2025 | 40972525 | PubTator, text mining | PubMed |
| Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson's Disease Mutations. | bioRxiv | 2025 | 40950074 | PubTator, text mining | PubMed |
| Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis. | J Pathol Clin Res | 2025 | 40906433 | PubTator, text mining | PubMed |
| The effect of U2AF1 mutation on erythroid differentiation and sensitivity to demethylation drug treatment. | Med Oncol | 2025 | 40886238 | PubTator, text mining | PubMed |
| Integrating multi-omics approaches in acute myeloid leukemia (AML): Advancements and clinical implications. | Clin Exp Med | 2025 | 40886194 | PubTator, text mining | PubMed |
| Effect of clonal hematopoiesis on plaque morphology and prognosis in patients with acute myocardial infarction. | Genome Med | 2025 | 40855342 | PubTator, text mining | PubMed |
| Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib. | Cancer | 2025 | 40839414 | PubTator, text mining | PubMed |
| Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms. | Blood Cancer J | 2025 | 40818987 | PubTator, text mining | PubMed |
| MALAT1 regulates mRNA processing through sequence dependent RNA-RNA and RNA-protein interactions. | Nucleic Acids Res | 2025 | 40808300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=6